Sequella Home Page

Quick Facts

HIV-infected people exposed to tuberculosis are 30 to 50 times more likely to develop active TB.

Therapeutics

INFECTIOUS DISEASE TARGET PRODUCT CANDIDATE R&D PHASE
Tuberculosis SQ109 Phase 2
Tuberculosis Sutezolid Phase 2
Tuberculosis SQ609 Preclinical
H. pylori Infections / Gastric Disease SQ109 Phase 2
Gram+ bacterial infections Sutezolid Phase 1 complete
C. difficile Infection SQ641 Preclinical
Crohn’s Disease SQ641
Research